October 28th, 2026 7:00~8:15 PM EDT | 4:00~5:15 PM PDT
This roundtable brings together leading experts to explore how advances in cardiac MRI, cardiac and coronary CT, and artificial intelligence (AI) are reshaping care for patients with hypertrophic cardiomyopathy (HCM). The panel will examine emerging image-acquisition technologies and AI-based tools help support diagnosis, treatment and risk stratification, along with strategies for partnering with patients to achieve better outcomes. Attendees will learn how intelligent imaging can improve care while keeping the patient at the center.
Upon completing this webinar, participants will be able to:
Moderator : Dr. Kanae Mukai, MD, FACC, ABIHM, FSCMR
Cardiologist
Medical Director of Non-Invasive Cardiovascular Imaging
Salinas Valley Memorial Hospital, Salinas, CA, the USA
Panelist : Ms. Lisa Salberg
Founder and Chief Executive Officer,
Hypertrophic Cardiomyopathy Association (HCMA),
New Jersey, USA
Panelist : Dr. Carlos Eduardo Rochitte, MD, PhD, FSCMR
Cardiologist,
Associate Professor of Cardiology,
Chief Medical Officer (CMO) / Medical Director of Research Center,
Heart Institute (InCor), University of São Paulo Medical School,
Director of Cardiovascular MR and CT,
Heart Hospital (HCOR), Dasa/Alta,
São Paulo, Brazil
The clinical results, performance and views described here are based upon the experience of the presenters. Results may vary due to clinical setting, patient presentation and other factors.